Blog Articles

Peptides are having a moment. There’s just one problem: Many of the most popular peptides on the market today are not currently permissible under the existing FDA regulatory framework. This post breaks down where these substances actually stand today and what all of this means for LegitScript-certified businesses operating within the US.

Nicotine products don’t look like nicotine products anymore, and that’s exactly the problem. Novel products are slipping past standard detection, while a backlogged FDA and a patchwork of state rules make consistent enforcement nearly impossible. A panel at Marketplace Risk’s New York conference dug into where the risk is hiding and what platforms can do.

From deepfake product photos to AI-generated NCII, trust and safety teams are facing a threat that shifts faster than most policies can keep up with. At Marketplace Risk’s New York conference, a panel of experts broke down the evasion tactics bad actors are using right now, the gray areas that trip up even experienced teams, and what it actually takes to build a policy that holds up.

Clearing accessibility and privacy compliance doesn’t give a healthcare business a free pass on its advertising. From unsubstantiated claims to tracking pixels that quietly trigger privacy laws, advertising carries its own fast-evolving risks. In episode 3 of our Protecting Your Business series, LegitScript sits down with Michael Williams of Clym to explore where advertising and disclosure scrutiny is headed, and how certification keeps what patients see aligned with the care they actually get.

Most healthcare businesses think privacy starts and ends with HIPAA. But a patchwork of consumer data privacy laws, now on the books in nearly two dozen states, can apply based on where a patient is browsing from, not where the business operates. In episode 2 of our Protecting Your Business series, LegitScript sits down with Michael Williams of Clym to unpack what it actually takes to manage privacy at scale, and why it matters most in behavioral health and addiction treatment.

Many healthcare businesses treat website accessibility as a checkbox: install a widget and move on. But that leaves them exposed to a fast-growing wave of litigation and misses the bigger point. In the first episode of our Protecting Your Business series, LegitScript sits down with Michael Williams of Clym to unpack why accessibility is an ongoing responsibility, and how it connects directly to the transparency patients rely on to make informed decisions about their care.

Increasingly, the value of LegitScript Certification is being recognized by a new market: the patients and consumers making decisions about where to get their medications and care. Keep reading to understand why this is important and how you can properly identify LegitScript-certified businesses.

Even the best controls aren’t perfect. As evasion tactics evolve faster than controls can adapt, platforms must start asking more questions about the violative behavior they aren’t seeing and how they can better address a confluence of challenges to stay ahead of what’s next. Read more.

One bad account is rarely just one bad account. Pull the thread and a single bad actor can unravel an entire criminal network interwoven throughout the internet. Here’s how investigation teams track the signals, differentiate between different kinds of networks, and turn scattered clues into enforcement that sticks.

LegitScript has launched two new reporting updates to keep client portfolios safe from merchants offering unauthorized tobacco products and illegal sales to minors. Keep reading to learn how we are helping payment processors and online platforms navigate this high-risk landscape.

Prediction markets promise crowdsourced forecasting, but they’re pulling payment processors into a regulatory gray zone. The CFTC treats them as futures contracts. Several states call them gambling. That split leaves acquirers and ISOs exposed to compliance risk they didn’t sign up for. Keep reading to learn more about these merchants.

A group of state attorneys general just told major card networks to stop processing for illegal vape sellers. Learn what the letter is asking card networks to do, and the exact questions banks, ISOs, and PSPs need to answer before regulators come knocking.

Brazil has embraced digital payments faster than almost anywhere else in the world. That growth is a genuine success story — and it has created an entirely new risk landscape that payments companies and online platforms cannot afford to ignore. Read more.

Last week’s Recovery.com Marketing Summit brought behavioral health marketers together around SEO, AI, attribution, and more, but one theme ran under every session: Trust is still how patients choose care. Here are the takeaways that stood out, and what they mean for how you market your treatment services.

Last week, the U.S. Food and Drug Administration’s Pharmacy Compounding Advisory Committee (PCAC) met to evaluate several peptide substances and make recommendations to the FDA regarding whether they should be included on the list of bulk drug substances. Keep reading to learn what this means for peptides businesses and their partners.